Tumor suppressors p53, p63TAα, p63TAy, p73α, and p73β use distinct pathways to repress telomerase expression

Journal of Biological Chemistry

Volumn 287, Issue 24, 2012, Pages 20737-20747

  Yao, Yuan ^a   Bellon, Marcia ^a   Shelton, Shary N ^a   Nicot, Christophe ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALYTIC SUBUNITS; LIFE SPAN; MOUSE CELLS; SOMATIC CELLS; TELOMERASE; TELOMERASE EXPRESSION; TUMOR SUPPRESSORS;

BIOCHEMISTRY; BIOLOGY;

TUMORS;

MYC PROTEIN; NUCLEAR FACTOR; NUCLEAR FACTOR YB2; PROTEIN P53; PROTEIN P63TAALPHA; PROTEIN P63TAGAMMA; PROTEIN P73ALPHA; PROTEIN P73BETA; TELOMERASE; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR SP1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ENZYME REPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; TRANSCRIPTION TERMINATION;

ANIMALS; CELL LINE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MICE; MICE, KNOCKOUT; NUCLEAR PROTEINS; PHOSPHOPROTEINS; TELOMERASE; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84862005661     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.319236     Document Type: Article

References (54)

1. Cong, Y. S., Wright, W. E., and Shay, J. W. (2002) Human telomerase and its regulation. Microbiol. Mol. Biol. Rev. 66, 407-425 (Pubitemid 35001137)
2. Lansdorp, P. M. (2008) Telomeres, stem cells, and hematology. Blood 111, 1759-1766
3. Deng, Y., Chan, S. S., and Chang, S. (2008) Telomere dysfunction and tumour suppression: the senescence connection. Nat. Rev. Cancer 8, 450-458 (Pubitemid 351744962)
4. Artandi, S. E., and DePinho, R. A. (2010) Telomeres and telomerase in cancer. Carcinogenesis 31, 9-18
5. Bellon, M., and Nicot, C. (2008) Regulation of telomerase and telomeres: human tumor viruses take control. J. Natl. Cancer Inst. 100, 98-108 (Pubitemid 351480562)
6. Horikawa, I., Cable, P. L., Afshari, C., and Barrett, J. C. (1999) Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res. 59, 826-830 (Pubitemid 29086735)
7. Takakura, M., Kyo, S., Kanaya, T., Hirano, H., Takeda, J., Yutsudo, M., and Inoue, M. (1999) Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res. 59, 551-557 (Pubitemid 29076049)
8. Cong, Y. S., Wen, J., and Bacchetti, S. (1999) The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum. Mol. Genet. 8, 137-142 (Pubitemid 29039059)
9. Horikawa, I., Michishita, E., and Barrett, J. C. (2004) Regulation of hTERT transcription: a target of cellular and viral mechanisms for immortalization and carcinogenesis. Cytotechnology 45, 23-32 (Pubitemid 40568820)
10. Kyo, S., Takakura, M., Taira, T., Kanaya, T., Itoh, H., Yutsudo, M., Ariga, H., and Inoue, M. (2000) Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res. 28, 669-677 (Pubitemid 30068249)
11. Sinha-Datta, U., Horikawa, I., Michishita, E., Datta, A., Sigler-Nicot, J. C., Brown, M., Kazanji, M., Barrett, J. C., and Nicot, C. (2004) Transcriptional activation of hTERT through the NF-κB pathway in HTLV-I-transformed cells. Blood 104, 2523-2531 (Pubitemid 39331856)
12. Chebel, A., Rouault, J. P., Urbanowicz, I., Baseggio, L., Chien, W. W., Salles, G., and Ffrench, M. (2009) Transcriptional activation of hTERT, the human telomerase reverse transcriptase, by nuclear factor of activated T cells. J. Biol. Chem. 284, 35725-35734
13. Goueli, B. S., and Janknecht, R. (2003) Regulation of telomerase reverse transcriptase gene activity by upstream stimulatory factor. Oncogene 22, 8042-8047 (Pubitemid 37175868)
14. Greenberg, R. A., O'Hagan, R. C., Deng, H., Xiao, Q., Hann, S. R., Adams, R. R., Lichtsteiner, S., Chin, L., Morin, G. B., and DePinho, R. A. (1999) Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene 18, 1219-1226 (Pubitemid 29085995)
15. Bellon, M., and Nicot, C. (2008) Central role of PI3K in transcriptional activation of hTERT in HTLV-I-infected cells. Blood 112, 2946-2955
16. Nakatake, M., Kakiuchi, Y., Sasaki, N., Murakami-Murofushi, K., and Yamada, O. (2007) STAT3 and PKC differentially regulate telomerase activity during megakaryocytic differentiation of K562 cells. Cell Cycle 6, 1496-1501
17. Hashimoto, M., Kyo, S., Hua, X., Tahara, H., Nakajima, M., Takakura, M., Sakaguchi, J., Maida, Y., Nakamura, M., Ikoma, T., Mizumoto, Y., and Inoue, M. (2008) Role of menin in the regulation of telomerase activity in normal and cancer cells. Int. J. Oncol. 33, 333-340
18. Li, H., and Liu, J. P. (2007) Mechanisms of action of TGF-β in cancer: evidence for Smad3 as a repressor of the hTERT gene. Ann. N.Y. Acad. Sci. 1114, 56-68 (Pubitemid 350070383)
19. Fujiki, T., Miura, T., Maura, M., Shiraishi, H., Nishimura, S., Imada, Y., Uehara, N., Tashiro, K., Shirahata, S., and Katakura, Y. (2007) TAK1 re-presses transcription of the human telomerase reverse transcriptase gene. Oncogene 26, 5258-5266 (Pubitemid 47237626)
20. Crowe, D. L., Nguyen, D. C., Tsang, K. J., and Kyo, S. (2001) E2F-1 re-presses transcription of the human telomerase reverse transcriptase gene. Nucleic Acids Res. 29, 2789-2794 (Pubitemid 32685042)
21. Cong, Y. S., and Bacchetti, S. (2000) Histone deacetylation is involved in the transcriptional repression of hTERT in normal human cells. J. Biol. Chem. 275, 35665-35668
22. Günes, C., Lichtsteiner, S., Vasserot, A. P., and Englert, C. (2000) Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1. Cancer Res. 60, 2116-2121 (Pubitemid 30225170)
23. Oh, S., Song, Y. H., Yim, J., and Kim, T. K. (2000) Identification of Mad as a repressor of the human telomerase (hTERT) gene. Oncogene 19, 1485-1490 (Pubitemid 30171181)
24. Oh, S., Song, Y., Yim, J., and Kim, T. K. (1999) The Wilms' tumor 1 tumor suppressor gene represses transcription of the human telomerase reverse transcriptase gene. J. Biol. Chem. 274, 37473-37478
25. Horikawa, I., Cable, P. L., Mazur, S. J., Appella, E., Afshari, C. A., and Barrett, J. C. (2002) Downstream E-box-mediated regulation of the human telomerase reverse transcriptase (hTERT) gene transcription: evidence for an endogenous mechanism of transcriptional repression. Mol. Biol. Cell 13, 2585-2597
26. Li, H., Xu, D., Li, J., Berndt, M. C., and Liu, J. P. (2006) Transforming growth factor β suppresses human telomerase reverse transcriptase (hTERT) by Smad3 interactions with c-Myc and the hTERT gene. J. Biol. Chem. 281, 25588-25600 (Pubitemid 44401948)
27. Sitaram, R. T., Degerman, S., Ljungberg, B., Andersson, E., Oji, Y., Sugiyama, H., Roos, G., and Li, A. (2010) Wilms' tumour 1 can suppress hTERT gene expression and telomerase activity in clear cell renal cell carcinoma via multiple pathways. Br. J. Cancer 103, 1255-1262
28. Kusumoto, M., Ogawa, T., Mizumoto, K., Ueno, H., Niiyama, H., Sato, N., Nakamura, M., and Tanaka, M. (1999) Adenovirus-mediated p53 gene transduction inhibits telomerase activity independent of its effects on cell cycle arrest and apoptosis in human pancreatic cancer cells. Clin. Cancer Res. 5, 2140-2147 (Pubitemid 29399270)
29. Giono, L. E., and Manfredi, J. J. (2006) The p53 tumor suppressor participates in multiple cell cycle checkpoints. J. Cell. Physiol. 209, 13-20 (Pubitemid 44318664)
30. Moll, U. M., and Slade, N. (2004) p63 and p73: roles in development and tumor formation. Mol. Cancer Res. 2, 371-386 (Pubitemid 39031071)
31. Pei, J. H., Luo, S. Q., Zhong, Y., Chen, J. H., Xiao, H. W., and Hu, W. X. (2011) The association between non-Hodgkin lymphoma and methylation of p73. Tumour Biol. 32, 1133-1138
32. Watanabe, T., Huang, H., Nakamura, M., Wischhusen, J., Weller, M., Kleihues, P., and Ohgaki, H. (2002) Methylation of the p73 gene in gliomas. Acta Neuropathol. 104, 357-362 (Pubitemid 36075399)
33. Corn, P. G., Kuerbitz, S. J., van Noesel, M. M., Esteller, M., Compitello, N., Baylin, S. B., and Herman, J. G. (1999) Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5′ CpG island methylation. Cancer Res. 59, 3352-3356 (Pubitemid 29334490)
34. Glasspool, R. M., Burns, S., Hoare, S. F., Svensson, C., and Keith, W. N. (2005) The hTERT and hTERC telomerase gene promoters are activated by the second exon of the adenoviral protein, E1A, identifying the transcriptional corepressor CtBP as a potential repressor of both genes. Neoplasia 7, 614-622 (Pubitemid 40967762)
35. Dietz, S., Rother, K., Bamberger, C., Schmale, H., Mössner, J., and Engeland, K. (2002) Differential regulation of transcription and induction of programmed cell death by human p53-family members p63 and p73. FEBS Lett. 525, 93-99
36. Kirschner, R. D., Sänger, K., Müller, G. A., and Engeland, K. (2008) Transcriptional activation of the tumor suppressor and differentiation gene S100A2 by a novel p63-binding site. Nucleic Acids Res. 36, 2969-2980 (Pubitemid 351737189)
37. Jost, C. A., Marin, M. C., and Kaelin, W. G., Jr. (1997) p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature 389, 191-194 (Pubitemid 27400602)
38. Bouwman, P., Göllner, H., Elsässer, H. P., Eckhoff, G., Karis, A., Grosveld, F., Philipsen, S., and Suske, G. (2000) Transcription factor Sp3 is essential for post-natal survival and late tooth development. EMBO J. 19, 655-661 (Pubitemid 30093738)
39. Benatti, P., Basile, V., Merico, D., Fantoni, L. I., Tagliafico, E., and Imbriano, C. (2008) A balance between NF-Y and p53 governs the pro- and anti-apoptotic transcriptional response. Nucleic Acids Res. 36, 1415-1428 (Pubitemid 351426096)
40. Guo, Z., Boekhoudt, G. H., and Boss, J. M. (2003) Role of the intronic enhancer in tumor necrosis factor-mediated induction of manganous superoxide dismutase. J. Biol. Chem. 278, 23570-23578 (Pubitemid 36830177)
41. Racek, T., Mise, N., Li, Z., Stoll, A., and Pützer, B. M. (2005) C-terminal p73 isoforms repress transcriptional activity of the human telomerase reverse transcriptase (hTERT) promoter. J. Biol. Chem. 280, 40402-40405 (Pubitemid 41780526)
42. Xu, D., Wang, Q., Gruber, A., Björkholm, M., Chen, Z., Zaid, A., Selivanova, G., Peterson, C., Wiman, K. G., and Pisa, P. (2000) Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells. Oncogene 19, 5123-5133
43. Dyson, N. (1998) The regulation of E2F by pRB-family proteins. Genes Dev. 12, 2245-2262
44. Datta, A., Bellon, M., Sinha-Datta, U., Bazarbachi, A., Lepelletier, Y., Canioni, D., Waldmann, T. A., Hermine, O., and Nicot, C. (2006) Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence. Blood 108, 1021-1029 (Pubitemid 44154640)
45. Löhr, K., Möritz, C., Contente, A., and Dobbelstein, M. (2003) p21/CDKN1A mediates negative regulation of transcription by p53. J. Biol. Chem. 278, 32507-32516 (Pubitemid 37055688)
46. Shats, I., Milyavsky, M., Tang, X., Stambolsky, P., Erez, N., Brosh, R., Kogan, I., Braunstein, I., Tzukerman, M., Ginsberg, D., and Rotter, V. (2004) p53-dependent down-regulation of telomerase is mediated by p21waf1. J. Biol. Chem. 279, 50976-50985 (Pubitemid 40017838)
47. Beitzinger, M., Oswald, C., Beinoraviciute-Kellner, R., and Stiewe, T. (2006) Regulation of telomerase activity by the p53 family member p73. Oncogene 25, 813-826 (Pubitemid 43237700)
48. Kanaya, T., Kyo, S., Hamada, K., Takakura, M., Kitagawa, Y., Harada, H., and Inoue, M. (2000) Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription. Clin. Cancer Res. 6, 1239-1247 (Pubitemid 30226203)
49. Ho, J. S., Ma, W., Mao, D. Y., and Benchimol, S. (2005) p53-dependent transcriptional repression of c-myc is required for G1 cell cycle arrest. Mol. Cell. Biol. 25, 7423-7431 (Pubitemid 41170106)
50. Moberg, K. H., Tyndall, W. A., and Hall, D. J. (1992) Wild-type murine p53 represses transcription from the murine c-myc promoter in a human glial cell line. J. Cell. Biochem. 49, 208-215
51. Hackzell, A., Uramoto, H., Izumi, H., Kohno, K., and Funa, K. (2002) p73 independent of c-Myc represses transcription of platelet-derived growth factor β-receptor through interaction with NF-Y. J. Biol. Chem. 277, 39769-39776 (Pubitemid 35190960)
52. Harley, C. B., Kim, N. W., Prowse, K. R., Weinrich, S. L., Hirsch, K. S., West, M. D., Bacchetti, S., Hirte, H. W., Counter, C. M., and Greider, C. W. (1994) Telomerase, cell immortality, and cancer. Cold Spring Harb. Symp. Quant. Biol. 59, 307-315
53. Gollahon, L. S., and Shay, J. W. (1996) Immortalization of human mammary epithelial cells transfected with mutant p53 (273his). Oncogene 12, 715-725
54. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254